Suppr超能文献

SPP1 通过驱动 M2 巨噬细胞浸润促进食管鳞癌的进展,代表了一个治疗靶点。

SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.

机构信息

Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, Henan, China.

Department of Nuclear Medicine, Xinxiang Central Hospital, Xinxiang, 453002, Henan, China.

出版信息

Br J Cancer. 2024 May;130(11):1770-1782. doi: 10.1038/s41416-024-02683-x. Epub 2024 Apr 10.

Abstract

BACKGROUND

Tumour-associated macrophages (TAMs) are an important component of the tumour microenvironment (TME). However, the crosstalk between oesophageal squamous cell carcinoma (ESCC) cells and TAMs remains largely unexplored.

METHODS

Clinical samples and the TCGA database were used to evaluate the relevance of SPP1 and TAM infiltration in ESCC. Mouse models were constructed to investigate the roles of macrophages educated by SPP1 in ESCC. Macrophage phenotypes were determined using qRT‒PCR and immunohistochemical staining. RNA sequencing was performed to elucidate the mechanism.

RESULTS

Increasing expression of SPP1 correlated with M2-like TAM accumulation in ESCC, and they both predicted poor prognosis in the ESCC cohort. Knockdown of SPP1 significantly inhibited the infiltration of M2 TAMs in xenograft tumours. In vivo mouse model experiments showed that SPP1-mediated education of macrophages plays an essential role in the progression of ESCC. Mechanistically, SPP1 recruited macrophages and promoted M2 polarisation via CD44/PI3K/AKT signalling activation and then induced VEGFA and IL6 secretion to sustain ESCC progression. Finally, blockade of SPP1 with RNA aptamer significantly inhibited tumour growth and M2 TAM infiltration in xenograft mouse models.

CONCLUSIONS

This study highlights SPP1-mediated crosstalk between ESCC cells and TAMs in ESCC. SPP1 could serve as a potential target in ESCC therapy.

摘要

背景

肿瘤相关巨噬细胞(TAMs)是肿瘤微环境(TME)的重要组成部分。然而,食管鳞状细胞癌(ESCC)细胞与 TAMs 之间的串扰在很大程度上仍未得到探索。

方法

使用临床样本和 TCGA 数据库评估 SPP1 和 TAM 浸润在 ESCC 中的相关性。构建小鼠模型以研究由 SPP1 教育的巨噬细胞在 ESCC 中的作用。使用 qRT-PCR 和免疫组织化学染色来确定巨噬细胞表型。进行 RNA 测序以阐明机制。

结果

SPP1 表达增加与 ESCC 中 M2 样 TAM 积累相关,并且它们都在 ESCC 队列中预测预后不良。SPP1 的敲低显著抑制了异种移植肿瘤中 M2 TAM 的浸润。体内小鼠模型实验表明,SPP1 介导的巨噬细胞教育在 ESCC 的进展中起着至关重要的作用。从机制上讲,SPP1 通过 CD44/PI3K/AKT 信号通路的激活招募巨噬细胞并促进 M2 极化,然后诱导 VEGFA 和 IL6 的分泌以维持 ESCC 的进展。最后,用 RNA 适体阻断 SPP1 可显著抑制异种移植小鼠模型中的肿瘤生长和 M2 TAM 浸润。

结论

这项研究强调了 SPP1 在 ESCC 中在 ESCC 细胞与 TAMs 之间的串扰。SPP1 可作为 ESCC 治疗的潜在靶点。

相似文献

3
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Theranostics. 2020 Sep 16;10(25):11535-11548. doi: 10.7150/thno.45261. eCollection 2020.
6
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.
Cell Mol Biol Lett. 2024 May 20;29(1):77. doi: 10.1186/s11658-024-00592-8.
8
Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
PLoS One. 2024 May 7;19(5):e0302780. doi: 10.1371/journal.pone.0302780. eCollection 2024.
9
Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation.
Cancer Med. 2025 Jan;14(2):e70604. doi: 10.1002/cam4.70604.

引用本文的文献

1
Cellular senescence in colorectal cancer: its occurrence, effect and therapy.
Front Oncol. 2025 Aug 15;15:1580951. doi: 10.3389/fonc.2025.1580951. eCollection 2025.
2
Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation.
Front Immunol. 2025 Jul 16;16:1585139. doi: 10.3389/fimmu.2025.1585139. eCollection 2025.
3
Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications.
MedComm (2020). 2025 Jun 16;6(7):e70256. doi: 10.1002/mco2.70256. eCollection 2025 Jul.
5
The Landscape of SPP1 Macrophages Across Tissues and Diseases: A Comprehensive Review.
Immunology. 2025 Oct;176(2):179-196. doi: 10.1111/imm.13952. Epub 2025 May 21.
6
Spatially segregated APOE macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma.
Theranostics. 2025 Apr 13;15(11):5312-5336. doi: 10.7150/thno.109097. eCollection 2025.
7
Decoding SPP1 regulation: Genetic and nongenetic insights into its role in disease progression.
Mol Cells. 2025 Apr 8;48(6):100215. doi: 10.1016/j.mocell.2025.100215.
8
Characterizing macrophage diversity in colorectal malignancies through single-cell genomics.
Front Immunol. 2025 Mar 21;16:1526668. doi: 10.3389/fimmu.2025.1526668. eCollection 2025.
9
SPP1 as a Prognostic and Immunotherapeutic Biomarker in Gliomas and Other Cancer Types: A Pan-Cancer Study.
J Inflamm Res. 2025 Feb 13;18:2247-2265. doi: 10.2147/JIR.S505237. eCollection 2025.

本文引用的文献

2
Macrophages in immunoregulation and therapeutics.
Signal Transduct Target Ther. 2023 May 22;8(1):207. doi: 10.1038/s41392-023-01452-1.
4
Macrophage Polarization: An Important Candidate Regulator for Lung Diseases.
Molecules. 2023 Mar 4;28(5):2379. doi: 10.3390/molecules28052379.
5
Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer.
Geroscience. 2023 Jun;45(3):1889-1898. doi: 10.1007/s11357-023-00742-4. Epub 2023 Mar 1.
6
The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.
Front Immunol. 2023 Jan 19;13:1039260. doi: 10.3389/fimmu.2022.1039260. eCollection 2022.
9
Neoadjuvant immunotherapy for resectable esophageal cancer: A review.
Front Immunol. 2022 Dec 8;13:1051841. doi: 10.3389/fimmu.2022.1051841. eCollection 2022.
10
Targeting macrophages: a novel treatment strategy in solid tumors.
J Transl Med. 2022 Dec 12;20(1):586. doi: 10.1186/s12967-022-03813-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验